Please wait while the formulary information is being retrieved.
TRIESENCE (TRIAMCINOLONE ACETONIDE/PF)
- Severe ocular inflammation
- Vitrectomy adjunct to enhance visualization
- Giant cell arteritis
- Ophthalmia sympathetic
- Uveitis
(PF) 40 mg/mL intraocular suspension
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Cerebral malaria
- Fungal infection of eye
- Herpes zoster keratitis
- Herpes zoster keratoconjunctivitis
- Ocular herpes simplex
- Tuberculosis of the eye
Contraindicated
- Cataracts
- Ocular hypertension
- Viral ocular infection
Severe
Moderate
- Diabetes mellitus
- Glaucoma
TRIESENCE (TRIAMCINOLONE ACETONIDE/PF)
- Severe ocular inflammation
- Vitrectomy adjunct to enhance visualization
- Giant cell arteritis
- Ophthalmia sympathetic
- Uveitis
- Cataracts
- Ocular hypertension
More Frequent
Severe
Less Severe
- Endophthalmitis
- Glaucoma
- Infection
- Ocular infection
- Blurred vision
- Increased appetite
- Ocular discomfort
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Allergic dermatitis
- Conjunctival hemorrhage
- Depression
- Diabetes mellitus
- Drug-induced psychosis
- Gastrointestinal hemorrhage
- Hypercortisolism
- Hypokalemia
- Hypopyon
- Hypothalamic-pituitary insufficiency
- Myopathy
- Osteoporosis
- Peptic ulcer
- Retinal detachment
- Skin rash
Less Severe
- Euphoria
- Gastric acid hypersecretory conditions
- Hirsutism
- Insomnia
- Irregular menstrual periods
- Mood changes
- Ocular inflammation
- Personality disorders
- Reduced visual acuity
- Skin hypopigmentation
- Vitreous floater
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Triamcinolone (oral,inj,intraoc.)
Chronic systemic use may cause growth suppression. Monitor growth rate, blood pressure, intraocular pressure etc. with continued use.
- 1 Day – 18 Years
- Chronic systemic use may cause growth suppression. Monitor growth rate, blood pressure, intraocular pressure etc. with continued use.
Triamcinolone (systemic)
- Severity Level:
C
- Additional Notes: Possible risk of orofacial clefts;category d for use in 1st trimester.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Triamcinolone (oral,inj)
Other systemic corticosteroids excreted; insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Other systemic corticosteroids excreted; insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Giant cell arteritis | |
| M31.5 | Giant cell arteritis with polymyalgia rheumatica |
| M31.6 | Other giant cell arteritis |
| Ophthalmia sympathetic | |
| H44.13 | Sympathetic uveitis |
| H44.131 | Sympathetic uveitis, right eye |
| H44.132 | Sympathetic uveitis, left eye |
| H44.133 | Sympathetic uveitis, bilateral |
| H44.139 | Sympathetic uveitis, unspecified eye |
| Severe ocular inflammation | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| Uveitis | |
| D86.83 | Sarcoid iridocyclitis |
| H20 | Iridocyclitis |
| H20.0 | Acute and subacute iridocyclitis |
| H20.00 | Unspecified acute and subacute iridocyclitis |
| H20.01 | Primary iridocyclitis |
| H20.011 | Primary iridocyclitis, right eye |
| H20.012 | Primary iridocyclitis, left eye |
| H20.013 | Primary iridocyclitis, bilateral |
| H20.019 | Primary iridocyclitis, unspecified eye |
| H20.02 | Recurrent acute iridocyclitis |
| H20.021 | Recurrent acute iridocyclitis, right eye |
| H20.022 | Recurrent acute iridocyclitis, left eye |
| H20.023 | Recurrent acute iridocyclitis, bilateral |
| H20.029 | Recurrent acute iridocyclitis, unspecified eye |
| H20.03 | Secondary infectious iridocyclitis |
| H20.031 | Secondary infectious iridocyclitis, right eye |
| H20.032 | Secondary infectious iridocyclitis, left eye |
| H20.033 | Secondary infectious iridocyclitis, bilateral |
| H20.039 | Secondary infectious iridocyclitis, unspecified eye |
| H20.04 | Secondary noninfectious iridocyclitis |
| H20.041 | Secondary noninfectious iridocyclitis, right eye |
| H20.042 | Secondary noninfectious iridocyclitis, left eye |
| H20.043 | Secondary noninfectious iridocyclitis, bilateral |
| H20.049 | Secondary noninfectious iridocyclitis, unspecified eye |
| H20.1 | Chronic iridocyclitis |
| H20.10 | Chronic iridocyclitis, unspecified eye |
| H20.11 | Chronic iridocyclitis, right eye |
| H20.12 | Chronic iridocyclitis, left eye |
| H20.13 | Chronic iridocyclitis, bilateral |
| H20.2 | Lens-induced iridocyclitis |
| H20.20 | Lens-induced iridocyclitis, unspecified eye |
| H20.21 | Lens-induced iridocyclitis, right eye |
| H20.22 | Lens-induced iridocyclitis, left eye |
| H20.23 | Lens-induced iridocyclitis, bilateral |
| H20.8 | Other iridocyclitis |
| H20.81 | Fuchs' heterochromic cyclitis |
| H20.811 | Fuchs' heterochromic cyclitis, right eye |
| H20.812 | Fuchs' heterochromic cyclitis, left eye |
| H20.813 | Fuchs' heterochromic cyclitis, bilateral |
| H20.819 | Fuchs' heterochromic cyclitis, unspecified eye |
| H20.9 | Unspecified iridocyclitis |
| H44.11 | Panuveitis |
| H44.111 | Panuveitis, right eye |
| H44.112 | Panuveitis, left eye |
| H44.113 | Panuveitis, bilateral |
| H44.119 | Panuveitis, unspecified eye |
| H44.13 | Sympathetic uveitis |
| H44.131 | Sympathetic uveitis, right eye |
| H44.132 | Sympathetic uveitis, left eye |
| H44.133 | Sympathetic uveitis, bilateral |
| H44.139 | Sympathetic uveitis, unspecified eye |
| 0-9 | A-Z |
|---|---|
| D86.83 | Sarcoid iridocyclitis |
| H20 | Iridocyclitis |
| H20.0 | Acute and subacute iridocyclitis |
| H20.00 | Unspecified acute and subacute iridocyclitis |
| H20.01 | Primary iridocyclitis |
| H20.011 | Primary iridocyclitis, right eye |
| H20.012 | Primary iridocyclitis, left eye |
| H20.013 | Primary iridocyclitis, bilateral |
| H20.019 | Primary iridocyclitis, unspecified eye |
| H20.02 | Recurrent acute iridocyclitis |
| H20.021 | Recurrent acute iridocyclitis, right eye |
| H20.022 | Recurrent acute iridocyclitis, left eye |
| H20.023 | Recurrent acute iridocyclitis, bilateral |
| H20.029 | Recurrent acute iridocyclitis, unspecified eye |
| H20.03 | Secondary infectious iridocyclitis |
| H20.031 | Secondary infectious iridocyclitis, right eye |
| H20.032 | Secondary infectious iridocyclitis, left eye |
| H20.033 | Secondary infectious iridocyclitis, bilateral |
| H20.039 | Secondary infectious iridocyclitis, unspecified eye |
| H20.04 | Secondary noninfectious iridocyclitis |
| H20.041 | Secondary noninfectious iridocyclitis, right eye |
| H20.042 | Secondary noninfectious iridocyclitis, left eye |
| H20.043 | Secondary noninfectious iridocyclitis, bilateral |
| H20.049 | Secondary noninfectious iridocyclitis, unspecified eye |
| H20.1 | Chronic iridocyclitis |
| H20.10 | Chronic iridocyclitis, unspecified eye |
| H20.11 | Chronic iridocyclitis, right eye |
| H20.12 | Chronic iridocyclitis, left eye |
| H20.13 | Chronic iridocyclitis, bilateral |
| H20.2 | Lens-induced iridocyclitis |
| H20.20 | Lens-induced iridocyclitis, unspecified eye |
| H20.21 | Lens-induced iridocyclitis, right eye |
| H20.22 | Lens-induced iridocyclitis, left eye |
| H20.23 | Lens-induced iridocyclitis, bilateral |
| H20.8 | Other iridocyclitis |
| H20.81 | Fuchs' heterochromic cyclitis |
| H20.811 | Fuchs' heterochromic cyclitis, right eye |
| H20.812 | Fuchs' heterochromic cyclitis, left eye |
| H20.813 | Fuchs' heterochromic cyclitis, bilateral |
| H20.819 | Fuchs' heterochromic cyclitis, unspecified eye |
| H20.9 | Unspecified iridocyclitis |
| H44.11 | Panuveitis |
| H44.111 | Panuveitis, right eye |
| H44.112 | Panuveitis, left eye |
| H44.113 | Panuveitis, bilateral |
| H44.119 | Panuveitis, unspecified eye |
| H44.13 | Sympathetic uveitis |
| H44.13 | Sympathetic uveitis |
| H44.131 | Sympathetic uveitis, right eye |
| H44.131 | Sympathetic uveitis, right eye |
| H44.132 | Sympathetic uveitis, left eye |
| H44.132 | Sympathetic uveitis, left eye |
| H44.133 | Sympathetic uveitis, bilateral |
| H44.133 | Sympathetic uveitis, bilateral |
| H44.139 | Sympathetic uveitis, unspecified eye |
| H44.139 | Sympathetic uveitis, unspecified eye |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| M31.5 | Giant cell arteritis with polymyalgia rheumatica |
| M31.6 | Other giant cell arteritis |
Formulary Reference Tool